| Oct 4, 12 | Shire could find new uses for hyperactivity drug says broker, as FTSE 100 caution continues | | No data |
| Sep 24, 12 | Yule Catto falls as bid hopes fade but speculation returns to Sainsbury | | No data |
| Sep 24, 12 | Shire and Smith & Nephew in demand as investors seek defensive stocks | | No data |
| Aug 1, 12 | Shire jumps 5% as results please while ECB and Federal Reserve hopes continue to spur markets | | No data |
| Jul 25, 12 | Arm adds 8% despite Apple disappointment while FTSE flatlines | | No data |
| Jul 2, 12 | AstraZeneca partners with Bristol-Myers to buy US group diabetes specialist Amylin for $7bn | | No data |
| Jun 29, 12 | EU summit deal lifts FTSE nearly 1.5% but Vodafone suffers on competition concerns | | No data |
| Jun 28, 12 | GlaxoSmithKline dips on renewed talk of interest in US group BioMarin | | No data |
| Jun 27, 12 | FTSE gains ahead of key EU summit, while Arm rises on long term growth prospects | | No data |
| Jun 26, 12 | FTSE falters ahead of EU summit while insurer Resolution hit by sell note | | No data |
| Jun 26, 12 | FTSE regains some ground but outsourcer Serco slides after cutting revenue expectations | | No data |
| Jun 25, 12 | FTSE closes down as markets across Europe suffer | | No data |
| Jun 25, 12 | Shire investors feeling gloomy after copycat drug approved | | No data |
| Jun 25, 12 | Eurozone fatigue sets in as markets open down | | No data |
| Jun 22, 12 | Pharma companies boosted as latest drugs approved by EU | | No data |
| Jun 15, 12 | Banks move higher after £180bn boost, helping FTSE end week on a positive note | | No data |
| Jun 13, 12 | Cairn leads bid flurry with North Sea deal, as FTSE edges higher ahead of Greek election | | No data |
| May 2, 12 | Banks lead FTSE lower on eurozone fears but InterContinental Hotels boosted by upgrade | | No data |
| Apr 4, 12 | FTSE 100 drops 2% on eurozone woes, while Next slides as Lord Wolfson sells £3.8m worth of shares | | No data |
| Apr 4, 12 | Shire backed by broker despite recent disappointments, but FTSE 100 slide continues | | No data |
| Mar 30, 12 | FTSE 100 ends quarter on upbeat note but Shire and Vodafone suffer | | No data |
| Mar 30, 12 | Shire slides 4% after disappointing trial results | | No data |
| Mar 23, 12 | Shire chairman took home £8.5m | | No data |
| Mar 15, 12 | Property groups British Land and Land Securities tipped as predators, while FTSE falters again | | No data |
| Mar 15, 12 | Essar Energy moves higher after refinery news, but FTSE 100 slips back | | No data |
| Mar 15, 12 | Shire withdraws US licence application for its Fabry disease treatment | | No data |
| Mar 6, 12 | Inmarsat falls despite profit rise, on worries about US partner LightSquared | | No data |
| Mar 2, 12 | International Power boosted by bid talk but FTSE fades as EU summit ends | | No data |
| Mar 1, 12 | Thomas Cook drops by a fifth on downgrade, but FTSE 100 moves higher as EU meets | | No data |
| Feb 27, 12 | Nomura suggests a pick-up in merger activity and tips 35 possible targets | | No data |